Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Vincent Leone

Orthopaedic Surgery Great Neck, NY Medical Doctor

NPI 1487667739 CMS profile 249390

833 Northern Blvd, Suite 220, Great Neck, NY 11021

Open in the dashboard

General payments

$158,686

79 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Vincent Leone of Great Neck, NY is reported in the CMS Open Payments database as having received $158,686 across 79 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,650 4
2024 General $12,184 6
2023 General $20,345 26
2022 General $30,187 17
2021 General $3,188 4
2020 General $31,988 12
2019 General $49,144 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vincent Leone
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Vincent Leone were reported at $11,650. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Vincent Leone Orthopaedic Surgery median Middle half National median
2019 $49,144 $644 $140–$2,844 $163
2020 $31,988 $312 $75–$1,860 $114
2021 $3,188 $520 $117–$2,495 $132
2022 $30,187 $598 $128–$2,731 $149
2023 $20,345 $461 $128–$2,264 $160
2024 $12,184 $497 $134–$2,475 $164
2025 $11,650 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $67,093 9 payments
  2. Zimvie Inc. $38,546 9 payments
  3. Highridge Medical LLC $23,490 6 payments
  4. Choice Spine, LLC $10,201 2 payments
  5. ulrich medical USA, Inc. $6,659 10 payments
  6. CoreLink, LLC $5,687 5 payments
  7. Cerapedics, Inc. $4,284 11 payments
  8. Medtronic, Inc. $2,125 21 payments
  9. Seaspine Orthopedics Corporation $292 2 payments
  10. 4WEB, Inc. $201 3 payments
  11. Other $109 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $144,877 30 payments
  2. Food and Beverage $6,031 31 payments
  3. Travel and Lodging $3,043 11 payments
  4. Entertainment $3,025 3 payments
  5. Consulting Fee $1,500 1 payment
  6. Education $210 3 payments
Products named General payments · program years 2019–2025
  1. ROI-A Spine $61,589 8 payments
  2. ROI-A Spine $43,910 9 payments
  3. ROI-A Spine $23,490 6 payments
  4. Silverbolt $10,201 2 payments
  5. I-FACTOR PEPTIDE ENHANCED BONE GRAFT $4,284 11 payments
  6. CD HORIZON SPINAL SYSTEM $1,450 13 payments
  7. MAZOR X SYSTEM $359 4 payments
  8. SPINE TRUSS SYSTEM $201 3 payments
  9. Mariner $172 1 payment
  10. Mobi-C $139 1 payment
  11. Other $545 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

341

Median for Orthopedic Surgery: 203

Drug cost

$2,000

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 70 $527
Methylprednisolone Generic 67 $415
Gabapentin Generic 73 $317
Meloxicam Generic 69 $232
Celecoxib Generic 14 $166
Ibuprofen Generic 24 $148
Tizanidine Hcl Generic 11 $105
Cyclobenzaprine Hcl Generic 13 $90

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$200,476

Of which drugs: $3,201

Medicare patients

629

Average age 74

Services billed

2,080

357 women, 272 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 39%
Diabetes 30%
Osteoporosis 21%
Cancer 20%
Depression 19%
COPD 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

79 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record